COMPANY PROFILE
Akums Drugs and Pharma L
6 Aug 2024 – 22 Dec 2025 · NSE
Price & disclosure history
Raw, unadjusted closes · purple markers show disclosed dates
Most active reported names
OFFICIAL SHAREHOLDING PATTERNS
Named shareholders
As of 30 Jun 2026 · NSE
Filing coverage: 12 collected index entries; 0 unresolved; 0 awaiting collection. Index entries can include revisions and irregular dates. Review coverage →
Only individually named holdings disclosed in available shareholding-pattern filings are shown. Reporting thresholds, missing filings and name differences leave other holdings unobserved. A name match is not verification of a legal identity; absence is not a zero holding. Estimated values use reported shares times an unadjusted official close no later than the reporting date, within seven calendar days; holdings without an eligible close have no value estimate. Scroll horizontally if needed.
AKUMS DRUGS AND PHARMACEUTICALS LIMITED · Listing ISIN INE09XN01023
| Reported shareholder | As of | Shares | Company stake | Estimated value | Category | Evidence |
|---|---|---|---|---|---|---|
| AKUMS MASTER TRUST (Sanjeev Jain and Sandeep Jain) | 30 Jun 2026 | 6,42,00,000 | 40.79% | ₹4,000.623 CrRaw close ₹623.15 · 30 Jun 2026 NSE | named shareholder | Official filing ↗NSE · named filing row |
| Sandeep Jain | 30 Jun 2026 | 2,71,27,690 | 17.24% | ₹1,690.462 CrRaw close ₹623.15 · 30 Jun 2026 NSE | promoter | Official filing ↗NSE · named filing row |
| Sanjeev Jain | 30 Jun 2026 | 2,71,13,940 | 17.23% | ₹1,689.6052 CrRaw close ₹623.15 · 30 Jun 2026 NSE | promoter | Official filing ↗NSE · named filing row |
| Franklin India Opportunites Fund | 30 Jun 2026 | 65,92,337 | 4.19% | ₹410.8015 CrRaw close ₹623.15 · 30 Jun 2026 NSE | named shareholder | Official filing ↗NSE · named filing row |
| Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund | 30 Jun 2026 | 49,43,282 | 3.14% | ₹308.0406 CrRaw close ₹623.15 · 30 Jun 2026 NSE | named shareholder | Official filing ↗NSE · named filing row |
| Akums Employee Benefits Trust | 30 Jun 2026 | 42,91,930 | 2.73% | ₹267.4516 CrRaw close ₹623.15 · 30 Jun 2026 NSE | named shareholder | Official filing ↗NSE · named filing row |
| Clarus Capital I | 30 Jun 2026 | 34,08,168 | 2.17% | ₹212.38 CrRaw close ₹623.15 · 30 Jun 2026 NSE | named shareholder | Official filing ↗NSE · named filing row |
| Bandhan Small Cap Fund | 30 Jun 2026 | 17,74,434 | 1.13% | ₹110.5739 CrRaw close ₹623.15 · 30 Jun 2026 NSE | named shareholder | Official filing ↗NSE · named filing row |
| Lata Jain | 30 Jun 2026 | 13,750 | 0.01% | ₹0.8568 CrRaw close ₹623.15 · 30 Jun 2026 NSE | promoter | Official filing ↗NSE · named filing row |
Complete disclosure history
Prices per share · ₹ · Values count reported sides · Scroll horizontally if needed
Scroll horizontally to see all columns →
| Date / exchange | Company | Reported participant | Side | Quantity | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| 2025-12-22NSEBulk | Akums Drugs and Pharma LAKUMS | RUBY QC INVESTMENT HOLDINGS PTE.LTD. | Sell | 72,78,535 | ₹428 | ₹311.52 Cr | NSE ↗ |
| 2025-12-22NSEBlock | Akums Drugs and Pharma LAKUMS | RUBY QC INVESTMENT HOLDINGS PTE.LTD. | Sell | 72,78,535 | ₹428 | ₹311.52 Cr | NSE ↗ |
| 2025-12-22NSEBulk | Akums Drugs and Pharma LAKUMS | ICICI PRUDENTIAL MUTUAL FUND | Buy | 72,78,535 | ₹428 | ₹311.52 Cr | NSE ↗ |
| 2025-12-22NSEBlock | Akums Drugs and Pharma LAKUMS | ICICI PRUDENTIAL MUTUAL FUND | Buy | 72,78,535 | ₹428 | ₹311.52 Cr | NSE ↗ |
| 2024-08-06NSEBulk | Akums Drugs and Pharma LAKUMS | SMALLCAP WORLD FUND INC | Buy | 25,86,541 | ₹753.84 | ₹194.98 Cr | NSE ↗ |
Names as reported
AKUMS
BLOCK.DEAL ARCHIVE
Company profileParticipant profileDaily disclosuresLoading page…
Retrieving the published disclosures.
Loading history…
BLOCK.DEAL ARCHIVE
Deal explorerSource receipt
Retrieving the requested published data.
Loading selection…